Cannabis Law Report

SEPTEMBER 22, 2021

Oxford Cannabinoid Technologies Holdings plc. . Access to Canopy Growth’s cannabinoid library including 335 derivatives and 14 patent families. As Canopy Growth remains focused on commercialisation, this agreement will grant OCT access to the Canopy Library to advance this research.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Cannabinoids 52

Cannabis Law Report

JUNE 28, 2021

Pharmaceutical and Medical Cannabis Leaders Zambon GmbH and Adven GmbH will Drive Medical Cannabis Supporting Treatments for Neurological Therapies. Zambon is a multinational pharmaceutical company that focuses on innovation and development with the aim to improve patients’ lives. The market for medical cannabis in Germany.

Access 105

Access Research and Development Pharmaceutical Therapy 105

Veriheal

JUNE 22, 2021

” The doorways opening to new cannabinoid research are monumental. Over the next decade, the United States could stand to see an explosion in the research of cannabinoid therapies. Go figure the federal government chose Mississippi to be the only state where researchers can access medical cannabis legally.

DEA 65

DEA Access Therapy Cannabinoids 65

Cannabis Law Report

JULY 28, 2021

On 1 June 2021, the Group announced an agreement with Voisin Consulting SARL (“VC”), a life sciences consultancy comprising over 200 professionals in the UK, US and India, with expertise in medical devices, cannabinoids, neurological disorders and addictions.

Cannabinoids 105

Cannabinoids Clinical Trials Safety Medicine 105

Cannabis Law Report

JUNE 1, 2022

This acquisition will accelerate Khiron’s growth in Europe by controlling the complete value chain for its products and gaining direct access to German pharmacies. Pharmadrug GmbH has been active worldwide for almost 40 years as a manufacturer and wholesaler of medicinal products and active pharmaceutical ingredients.

Pharmaceutical 52

Pharmaceutical Medicine Extraction Cannabinoids 52

Canna Care Docs

NOVEMBER 4, 2024

Common treatments for chronic pain can include: Pharmaceuticals (painkillers, anti-inflammatories) Physical therapy Lifestyle changes (exercise, diet) Despite medical advancements, many patients find these methods still don’t offer adequate relief. These cannabinoids work directly with the body’s endocannabinoid system (ECS).

Chronic Pain 111

Chronic Pain Nerve Pain Treatment Cannabinoids 111

Peninsula Alternative Health

MAY 15, 2019

Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy. However, because cannabinoids reduce seizures through numerous mechanisms of actions, possible drug interactions are still unclear.

Conditions 89

Conditions Therapy Cannabinoids Epilepsy 89

Cannabis Law Report

OCTOBER 27, 2021

a vertically integrated provider of safe and sustainable specialty ingredients, today announced that it has successfully completed commercial-scale, fermentation-based production campaigns for its Lygos CBx cannabinoid products, including CBG (cannabigerol), CBC (cannabichromene), CBD (cannabidiol), and CBDA (cannabidiolic acid).

Cannabinoids 52

Cannabinoids Pharmaceutical Agriculture CBD 52

Cannabis Law Report

OCTOBER 26, 2019

The US subsidiary of GW Pharmaceuticals, behind the only FDA-approved cannabis extract-based medicine, is lobbying in all 50 states. GW is the world’s oldest and largest pharmaceutical company solely focused on producing medicines derived from cannabis plants, which it grows in Britain. By Nikitha Sattiraju.

Pharmaceutical 45

Pharmaceutical Research and Development Banking Therapy 45

Cannabis Law Report

SEPTEMBER 24, 2019

Here is the BBC report and below you will find the full press release from GW Pharmaceuticals. The medication, developed by GW Pharmaceuticals, will be used in combination with another epilepsy medication called clobazam. What about other medical cannabis products? There are many different medical cannabis products. .

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

Cannabis Law Report

FEBRUARY 7, 2023

Under this new program, Protonify will provide cannabis researchers with complimentary access to its high-purity, pharmaceutical-grade cannabinoid ingredients including THC concentrate and THCA isolate.

Pharmaceutical 52

Pharmaceutical Cannabinoids Concentrates THC 52

Cannabis Law Report

DECEMBER 1, 2021

BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by delaying aging, today announced that it will participate in two investor conferences during the month of December 2021. MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Chronic Pain Therapy 52

Project CBD

AUGUST 23, 2023

Earlier this year, the Food & Drug Administration disclosed that it would not regulate non-pharmaceutical CBD products, thereby putting the onus on Congress to devise an appropriate regulatory framework for cannabidiol and other hemp-derived cannabinoids. percent on a dry weight basis.”

Cannabinoids 141

Cannabinoids Hemp THC Safety 141

Project CBD

MAY 3, 2023

Goldstein will be leading the Medical Practicum at CannMed 2023 (May 15-17), where she will also be speaking about CBG and other minor cannabinoids during the main session. You have said that cannabigerol, or CBG, is one of your favorite cannabinoids. Is that because CBG is a precursor for the other plant cannabinoids?

Cannabinoids 209

Cannabinoids Sleep Clinical Trials CBD 209

Project CBD

FEBRUARY 28, 2023

sativa do not naturally contain cannabinoids, but they can become contaminated with CBD from other plant parts during processing. Accessed July 25, 2021. Available at: [link] Accessed October 17, 2022. Accessed October 17, 2022. Accessed October 17, 2022. Accessed October 17, 2022. Accessed October 17, 2022.

CBD 144

CBD Seed-To-Sale Food Access 144

Veriheal

AUGUST 9, 2023

Recent research reaffirms earlier studies that claim that certain non-marijuana plants contain similar compounds found in cannabis, often called cannabinoids. Even more, CBD is the first FDA-approved pharmaceutical drug for two rare forms of epileptic seizures in kids.

CBD 96

CBD Cannabinoids THC Extraction 96

Cannabis Info

OCTOBER 4, 2019

The Scientist Who Identified THC Is Now Working on Synthetic Cannabinoids. Dr. Raphael Mechoulam , the scientist who first recognized the THC molecule in 1965, introduced his latest mission in California final week: constructing artificial cannabinoids. The plant produces a group of compounds called cannabinoid acids.

Cannabinoids 45

Cannabinoids THC Wellness and Beauty Research and Development 45

Cannabis Law Report

JANUARY 13, 2020

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. Work with U.S. Mike Beyer.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66

Cannabis Law Report

SEPTEMBER 7, 2022

The acquisition by Ramm provides access to HemPoland’s distribution network, recognized premium brands, hemp oil extraction technologies, and an additional synergistic foothold into the European market following the acquisition of Sicily-based Canapar Corp. About RAMM Pharma Corp.

Hemp 59

Hemp Pharmaceutical Extraction Cannabinoids 59

Peninsula Alternative Health

MAY 15, 2019

Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy. However, because cannabinoids reduce seizures through numerous mechanisms of actions, possible drug interactions are still unclear.

Conditions 40

Conditions Therapy Cannabinoids Epilepsy 40

Veriheal

SEPTEMBER 27, 2021

The United Kingdom’s Multiple Sclerosis (MS) Society has taken a stand against restricted access to medical cannabis in the country. Medical cannabis has been legal in the nation for almost three years—so why are MS patients struggling to access the treatment? Yet many people with MS are still unable to access it.”

Treatment 98

Treatment Patients Access Research and Development 98

United Patients Group

MAY 17, 2023

Some researchers believe that cannabinoids may help people with ASD manage anxiety and stress by increasing their ability to focus and pay attention. Cannabinoids have been shown to help people with autism manage anxiety and stress.

Sleep 105

Sleep Cannabinoids Patients CBD 105

Veriheal

SEPTEMBER 20, 2021

Now, the latest trend among folks living in states without access to legal cannabis is THC-O. While THC-O could be considered a cannabinoid, it’s better described as a compound due to being synthetically derived from hemp. Cannabinoid therapies and research have started to advance across the United States.

THC 98

THC Cannabinoids Vaping Hemp 98

Veriheal

AUGUST 13, 2020

In talking about cannabis and its uses, a lot of attention is always paid to THC, the most well known cannabinoid in the cannabis plant. CBD is a non-intoxicating cannabinoid that offers many of the same medical benefits as THC. Just a few months ago, Dr. Mechoulam discovered an all-new cannabinoid previously unknown to anyone.

Cannabinoids 98

Cannabinoids Chronic Pain Sleep Pharmaceutical 98

The Cannigma

FEBRUARY 1, 2023

Even if a cannabinoid has shown promise on one cancer line, that doesn’t mean it will work for all cancers – even if it’s within the same organ system. Advocate for the rescheduling of cannabis to improve access to cannabis for research purposes, and scientific funding for novel cannabinoid-based cancer therapies.

Clinical Trials 145

Clinical Trials Research and Development Therapy Cannabinoids 145

The Cannigma

JUNE 2, 2022

Ever wondered how cannabinoids like THC or CBD affect your blood? The short answer is – no, in most cases cannabinoids do not seem to act as strong blood thinners. In this study the authors speculated that cannabinoids may be inhibiting an enzyme in blood plasma called thrombin, which promotes blood clotting.

Blood Pressure 114

Blood Pressure Cannabinoids Patients THC 114

MMJ Recs

AUGUST 1, 2024

Derived from the Cannabis plant, it contains cannabinoids like tetrahydrocannabinol (THC) and cannabidiol (CBD). The appeal of medical marijuana lies in its natural origin and holistic approach, offering an alternative to traditional pharmaceuticals with fewer side effects. Why HIV/AIDS Patients Should Consider Medical Marijuana?

Patients 52

Patients Chronic Pain Marijuana Sleep 52

Cannabis Law Report

JULY 5, 2021

Bod also has a prescription product available to Australians – a pharmaceutical grade cannabidiol (CBD) based formulation called Medicabilis. Back in May, the company said it was launching a new product based on another cannabinoid – cannabigerol (CBG) – which will be sold under the MediCabilis brand as MediCabilis CBG 50 in the UK.

Cannabinoids 95

Cannabinoids CBD Pharmaceutical Access 95

Cannabis Law Report

FEBRUARY 27, 2022

The research and development company simultaneously retains its listing of shares on the Australian Stock Exchange, but notes that the dual listing means it is more accessible to a wider audience of investors “with sophisticated understandings of medicinal cannabinoids, psychedelic therapies, and pharmaceutical development”.

Medicine 52

Medicine Research and Development Therapy Pharmaceutical 52

MJ Business Attorneys

JUNE 29, 2018

DEA, the DEA expressed in their brief that they do not wish to control cannabinoids, but rather only those cannabinoids derived from the flowers and resins of a cannabis plant above.3%

DEA 113

DEA CBD Pharmaceutical Research and Development 113

Cannabis Law Report

APRIL 29, 2022

to expand its capabilities into Europe’s largest medical cannabis market and gain access to around 20,000 pharmacies in Germany through its affiliate Clever Leaves Germany GmbH. Clever Leaves Holdings Inc. BOCA RATON, Fla. and HAMBURG, Germany, April 27, 2022 (GLOBE NEWSWIRE) — Clever Leaves Holdings Inc.

Pharmaceutical 52

Pharmaceutical Compliance Compliance Cannabinoids 52

MMJ Recs

MAY 23, 2024

Medical Marijuana for Chronic Illness Management The traditional approach to managing chronic illnesses often involves a combination of pharmaceutical medications and lifestyle modifications. With its diverse array of cannabinoids, such as THC and CBD, medical marijuana offers a multifaceted approach to addressing chronic symptoms.

Conditions 105

Conditions Chronic Pain Therapy Marijuana 105

Cannabis Law Report

OCTOBER 26, 2021

Following this selection, Tilray will supply a variety of its pharmaceutical-grade medical cannabis products, including extracts and dried flower with different degrees of THC and CBD for patients with varying medical conditions.

Pharmaceutical 52

Pharmaceutical Research and Development Patients Access 52

Cannabis Law Report

MARCH 29, 2022

to acquire Dutch medical cannabis company APIRx Pharmaceutical BV. Incannex was one of the first ASX-listed companies to make forays into cannabinoid and psychedelic therapeutic drugs (it was originally a direct-to-consumer dental business, which disrupted the dental space).

Pharmaceutical 52

Pharmaceutical Cannabinoids Data Policy 52

Cannabis Law Report

SEPTEMBER 3, 2021

Flora Lab is acknowledged for its quality procedures which are now in line with global pharmaceutical companies after it receives GMP certification from INVIMA to manufacture cosmetics products. Has the capability to produce cannabinoid-containing products, including cannabidiol (“CBD”). Dietary Supplements. About Flora Growth Corp.

Supply Chain 93

Supply Chain Wellness and Beauty Pharmaceutical Cannabinoids 93

MMJ Recs

JUNE 30, 2024

Common Types of Edibles for Medicinal Marijuana Patients Medical marijuana patients have access to a diverse array of cannabis-infused edibles , each offering unique advantages in terms of dosage, onset time, and duration of effects. Image by Elsa Olofsson on Unsplash.

Edibles 111

Edibles Oil Packaging Patients 111

Cannabis Law Report

JANUARY 14, 2022

Is it a natural response to the fact that recreational is supposedly on the way or a the report suggests it’s hard as a patient to access so therefore people are just giving up. The current lack of market growth reflects an unfortunate reality in Germany that patient access to medical cannabis is still quite low.

Pharmaceutical 52

Pharmaceutical Extraction Oil Patients 52